Editor’s note: For more on engaging patients to be active participants in their own care, see the February issue of Health Affairs, “New Era Of Patient Engagement.” Currently, most hospitals and ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, making it the first ...

Imperative Care Presents Positive Real-World Data from Ischemic Stroke Patients Treated with ADAPT 2.0 Using the Zoom Stroke System Late-Breaking Data Presented at Society of Vascular and ...

This clearance expands the use of Symphony – previously for the treatment of venous thrombosis – to now include PE, providing a comprehensive solution to effectively and efficiently treat the full ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc., a company singularly dedicated to answering unsolved problems in stroke, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Final Imperative Trial Data Show the Zoom System Delivered the Fastest Median Case Time in A Well-Controlled, Rigorous Study 1 Clinical evidence submitted to the FDA to support the clearance included ...

Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...